Episode notes
Join Dr. Nicholas Silvestri in this 10-minute, special edition podcast series on myasthenia gravis (MG). Today’s podcast titled, Innovations in MG Therapeutics, focuses on the latest therapies, including complement inhibitors and FcRn antagonists, and their application in personalized treatment plans.
Launch Date: April 21, 2025
Release Date: April 21, 2025
Expiration Date: March 31, 2026
FACULTY
Nicholas Silvestri, MD, FAAN
Professor of Neurology, Associate Dean for Student and Academic Affairs
Department of Neurology
Jacobs School of Medicine & Biomedical Sciences
This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided